FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2329242225> ?p ?o ?g. }

• W2329242225 endingPage "990" @default.
• W2329242225 startingPage "983" @default.
• W2329242225 abstract "Effects of recombinant human granulocyte colony-stimulating factor (rhG-CSF, filgrastim) on hematopoietic recovery and clinical outcome in patients undergoing allogeneic bone marrow transplantation (BMT) from volunteer unrelated donors (VUD) were analyzed retrospectively. Additionally, the influence of baseline patient and transplant characteristics on hematopoietic recovery was evaluated. From January 1994 to March 1996, 47 consecutive adult patients received VUD-BMT. GVHD prophylaxis was cyclosporin A/short course methotrexate/prednisolone, and in four patients additional ATG. Post-transplantation, cohorts of patients received rhG-CSF (5 μg/kg/day) (n = 22) or no rhG-CSF (n = 25) in a non-randomized manner. The patient groups with and without rhG-CSF were rather comparable with respect to baseline patient and transplant characteristics. Median time to neutrophil counts (ANC) >500/μl was 14 days with rhG-CSF vs 16 days without rhG-CSF (P = 0.048), to ANC >1000/μl was 15 vs 18 days (P = 0.084). Neutrophil recovery was accelerated in patients receiving more than the median MNC dose of 2.54 × 108/kg with a median time to ANC >1000/μl of 13 days vs 19 days (P = 0.017). RhG-CSF did not influence platelet recovery and incidence of infectious complications. Incidence of acute GVHD II–IV was 50% with rhG-CSF and 28% without rhG-CSF (P = 0.144), but death before acute GVHD II–IV occurred in 9% of patients with and 20% of patients without rhG-CSF. The median follow-up time was 38 and 36 months in patients with and without rhG-CSF, respectively. Survival at 2 years post-transplant was 39% (95% confidence interval (18%, 60%)) in patients with rhG-CSF and 24% (95% confidence interval (7%, 41%)) in patients without rhG-CSF. Administration of rhG-CSF after VUD-BMT may lead to more rapid neutrophil recovery, but did not influence the incidence of infectious complications. Patients receiving rhG-CSF showed a slightly higher incidence of acute GVHD II–IV. Higher numbers of MNC in the marrow graft accelerated hematopoietic engraftment." @default.
• W2329242225 created "2016-06-24" @default.
• W2329242225 creator A5002333415 @default.
• W2329242225 creator A5023827344 @default.
• W2329242225 creator A5035666187 @default.
• W2329242225 creator A5055006530 @default.
• W2329242225 creator A5074339903 @default.
• W2329242225 creator A5077123460 @default.
• W2329242225 creator A5082920254 @default.
• W2329242225 date "1999-05-01" @default.
• W2329242225 modified "2023-10-16" @default.
• W2329242225 title "Influence of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donors" @default.
• W2329242225 cites W1565345042 @default.
• W2329242225 cites W1881943990 @default.
• W2329242225 cites W1987778665 @default.
• W2329242225 cites W2006204311 @default.
• W2329242225 cites W2019907028 @default.
• W2329242225 cites W202042235 @default.
• W2329242225 cites W2027827298 @default.
• W2329242225 cites W2029248205 @default.
• W2329242225 cites W2040436940 @default.
• W2329242225 cites W2053278212 @default.
• W2329242225 cites W2115046789 @default.
• W2329242225 cites W2119109249 @default.
• W2329242225 cites W2163682534 @default.
• W2329242225 cites W2261028267 @default.
• W2329242225 cites W2317117822 @default.
• W2329242225 cites W2337106692 @default.
• W2329242225 cites W2337809718 @default.
• W2329242225 cites W2396187023 @default.
• W2329242225 cites W2396497039 @default.
• W2329242225 cites W2402094753 @default.
• W2329242225 cites W2413259922 @default.
• W2329242225 cites W2414573815 @default.
• W2329242225 cites W2416793533 @default.
• W2329242225 cites W2416821736 @default.
• W2329242225 cites W2421351592 @default.
• W2329242225 cites W2423611949 @default.
• W2329242225 cites W2472331905 @default.
• W2329242225 cites W595140544 @default.
• W2329242225 doi "https://doi.org/10.1038/sj.bmt.1701746" @default.
• W2329242225 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7091765" @default.
• W2329242225 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10373062" @default.
• W2329242225 hasPublicationYear "1999" @default.
• W2329242225 type Work @default.
• W2329242225 sameAs 2329242225 @default.
• W2329242225 citedByCount "33" @default.
• W2329242225 countsByYear W23292422252012 @default.
• W2329242225 countsByYear W23292422252013 @default.
• W2329242225 countsByYear W23292422252016 @default.
• W2329242225 countsByYear W23292422252017 @default.
• W2329242225 countsByYear W23292422252022 @default.
• W2329242225 crossrefType "journal-article" @default.
• W2329242225 hasAuthorship W2329242225A5002333415 @default.
• W2329242225 hasAuthorship W2329242225A5023827344 @default.
• W2329242225 hasAuthorship W2329242225A5035666187 @default.
• W2329242225 hasAuthorship W2329242225A5055006530 @default.
• W2329242225 hasAuthorship W2329242225A5074339903 @default.
• W2329242225 hasAuthorship W2329242225A5077123460 @default.
• W2329242225 hasAuthorship W2329242225A5082920254 @default.
• W2329242225 hasBestOaLocation W23292422252 @default.
• W2329242225 hasConcept C120665830 @default.
• W2329242225 hasConcept C121332964 @default.
• W2329242225 hasConcept C126322002 @default.
• W2329242225 hasConcept C141071460 @default.
• W2329242225 hasConcept C2776694085 @default.
• W2329242225 hasConcept C2776715498 @default.
• W2329242225 hasConcept C2777767877 @default.
• W2329242225 hasConcept C2779171977 @default.
• W2329242225 hasConcept C2780007613 @default.
• W2329242225 hasConcept C2911091166 @default.
• W2329242225 hasConcept C61511704 @default.
• W2329242225 hasConcept C71924100 @default.
• W2329242225 hasConcept C90924648 @default.
• W2329242225 hasConceptScore W2329242225C120665830 @default.
• W2329242225 hasConceptScore W2329242225C121332964 @default.
• W2329242225 hasConceptScore W2329242225C126322002 @default.
• W2329242225 hasConceptScore W2329242225C141071460 @default.
• W2329242225 hasConceptScore W2329242225C2776694085 @default.
• W2329242225 hasConceptScore W2329242225C2776715498 @default.
• W2329242225 hasConceptScore W2329242225C2777767877 @default.
• W2329242225 hasConceptScore W2329242225C2779171977 @default.
• W2329242225 hasConceptScore W2329242225C2780007613 @default.
• W2329242225 hasConceptScore W2329242225C2911091166 @default.
• W2329242225 hasConceptScore W2329242225C61511704 @default.
• W2329242225 hasConceptScore W2329242225C71924100 @default.
• W2329242225 hasConceptScore W2329242225C90924648 @default.
• W2329242225 hasIssue "10" @default.
• W2329242225 hasLocation W23292422251 @default.
• W2329242225 hasLocation W23292422252 @default.
• W2329242225 hasLocation W23292422253 @default.
• W2329242225 hasLocation W23292422254 @default.
• W2329242225 hasOpenAccess W2329242225 @default.
• W2329242225 hasPrimaryLocation W23292422251 @default.
• W2329242225 hasRelatedWork W130519244 @default.
• W2329242225 hasRelatedWork W1861808521 @default.
• W2329242225 hasRelatedWork W1987787394 @default.
• W2329242225 hasRelatedWork W1992559636 @default.

• next